Oxcarbazepine Tablet, Extended Release
Product Images NDC 60505-4128

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 60505-4128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl150mg100s (Lbl150mg100s)

Label for Oxcarbazepine Extended-Release Tablets 150 mg, oral tablets in a package of 100. The label includes storage instructions, dosage form, and a note to see the package insert for dosage. Manufactured by Apotex Inc., Toronto, Ontario, and labeled for Apotex Corp., Weston, Florida. The label features the NDC 60505-4128-7 and the Apotex Corp. logo.*

FDA Label Image

Lbl300mg100s (Lbl300mg100s)

The label is for Oxcarbazepine Extended-Release Tablets, 300 mg strength, in a package of 100 tablets. Manufactured by Apotex Inc. and labeled for Apotex Corp., it includes storage instructions, usage directions to swallow whole once daily, and a barcode with NDC 60505-4129-7. The label is predominantly white with teal and yellow blocks highlighting the product name and strength.*

FDA Label Image

Lbl600mg100s (Lbl600mg100s)

Label for Oxcarbazepine Extended-Release Tablets 600 mg, oral dosage form, containing 100 tablets. The label includes storage instructions, dispensing warnings, and manufacturer information for Apotex Corp. The product is marked as prescription only (Rx Only).*

FDA Label Image

Structure-1 (Structure 1)

Chemical structure of oxcarbazepine, showing its molecular framework with fused rings, a ketone group, and an amide side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.